House GOP Targets US FDA Applications With China-Only Data, Cites General Oversight Concerns

 
• By Derrick Gingery
  
US-China chess pieces
House GOP leaders requested the GAO review BIMO's challenges overseeing research in the US and overseas. • Source: Shutterstock

More from Clinical Trials

More from R&D